Expression vector of human p53.
Alternative name | SET-0136_2-5 |
---|---|
Clone info. | Expression vector of human p53. Expression was confirmed by Western blotting with anti-FLAG antibody. |
Comment | PCR cloning, forward primer: gaggagccgcagtcagatcc; reverse primer: tcagtctgagtcaggcccttc. |
Vector backbone | pCMV_S-FLAG (RDB05956) (Plasmid) |
Size of vector backbone | 5.5 kb |
Selectable markers | Amp^r (E. coli), Neo^r (mammalian cell) |
Growth conditions | 37C, LB+Amp |
Gene/insert name | Human tumor protein p53 cDNA |
Depositor|Developer | DNA Bank, | |
Remarks, protocol and/or map (pdf) | RDB06754.pdf |
---|
Please check terms and conditions set forth by the depositor, which are specified in the RIKEN BRC Catalog and/or Web Catalog.
Ordering forms | Order form [Credit Card Payment ![]() ![]() ![]() MTA, for use for not-for-profit academic purpose [Word ![]() ![]() MTA, for use for for-profit purpose [Word ![]() Please visit Information of Request for Distribution.[link] |
---|---|
Terms and conditions for distribution | The RECIPIENT agrees to describe RIKEN BRC as the source of the MATERIAL in any publication. Additional terms and conditions: Regrding pRc/CMV: a) The modified pRc/CMV, and their descendants (collectively, LIFE MATERIALS), should be used for pre-clinical/non-human, research use only. b) LIFE MATERIALS shall not be used for any commercial purposes. c) LIFE MATERIALS shall not be transferred beyond the specified recipient. d) Recipient must contact Thermo Fisher Scientific Inc. at outlicense@thermofisher.com for any desired use of LIFE MATERIALS beyond the scope of a) to c) above. |
必要書類 | 提供依頼書 ![]() ![]() 提供同意書 (MTA, 非営利学術目的用)[Word ![]() ![]() 提供同意書 (MTA, 営利目的用)[Word ![]() 手続きの概要は、「提供申込みについて[link]」をご覧ください。 |
---|---|
MTAに書く使用条件 | 発表に際し、理研BRCから入手したことを明記すること。 付加的使用条件: pRc/CMVについて: a) The modified pRc/CMV, and their descendants (collectively, LIFE MATERIALS), should be used for pre-clinical/non-human, research use only. b) LIFE MATERIALS shall not be used for any commercial purposes. c) LIFE MATERIALS shall not be transferred beyond the specified recipient. d) Recipient must contact Thermo Fisher Scientific Inc. at outlicense@thermofisher.com for any desired use of LIFE MATERIALS beyond the scope of a) to c) above. |
Catalog # | Resource name | Shipping form | Fee |
---|---|---|---|
RDB06754 | pCMFlag_hsTP53 | DNA solution |
JPY 9,460 (not-for-profit academic purpose) JPY 18,920 (for-profit-research purpose) plus cost of shipping containers, dry ice (if required) and shipping charge |
Materials & Methods section:
The pCMFlag_hsTP53 was provided by the RIKEN BRC through the National BioResource Project of the MEXT, Japan (cat. RDB06754). |
Reference section:
Further references such as user reports and related articles (go to bottom)
RIKEN BRC has sequenced portions of this material for quality test.
Please review the QC test results indicated by icon as well as clone information before placing your order.
Test sheet | RDB13744_A5Lop1.pdf ![]() |
---|
Nucleotide sequence of a portion of this resource (if available).
Primer: CMV-Forward Sequence file: RDB13744_A5Loa.seq ![]() |
---|
>06754_13744_A5Lo_CMV-Forward_A03_03.ab1 1 TAATCAACTC CGCCCCATTG ACGCAATGGG CGGTAGGCGT GTACGGTGGG AGGTCTATAT 61 AAGCAGAGCT CTCTGGCTAA CTAGAGAACC CACTGCTTAC TGGCTTATCG AAATTAATAC 121 GACTCACTAT AGGGAGACCC AAGCTGAATT CACCATGGAC TACAAGGACG ATGACGATAA 181 GGCGGCCGAG GAGCCGCAGT CAGATCCTAG CGTCGAGCCC CCTCTGAGTC AGGAAACATT 241 TTCAGACCTA TGGAAACTAC TTCCTGAAAA CAACGTTCTG TCCCCCTTGC CGTCCCAAGC 301 AATGGATGAT TTGATGCTGT CCCCGGACGA TATTGAACAA TGGTTCACTG AAGACCCAGG 361 TCCAGATGAA GCTCCCAGAA TGCCAGAGGC TGCTCCCCCC GTGGCCCCTG CACCAGCAGC 421 TCCTACACCG GCGGCCCCTG CACCAGCCCC CTCCTGGCCC CTGTCATCTT CTGTCCCTTC 481 CCAGAAAACC TACCAGGGCA GCTACGGTTT CCGTCTGGGC TTCTTGCATT CTGGGACAGC 541 CAAGTCTGTG ACTTGCACGT ACTCCCCTGC CCTCAACAAG ATGTTTTGCC AACTGGCCAA 601 GACCTGCCCT GTGCAGCTGT GGGTTGATTC CACACCCCCG CCCGGCACCC GCGTCCGCGC 661 CATGGCCATC TACAAGCAGT CACAGCACAT GACGGAGGTT GTGAGGCGCT GCCCCCACCA 721 TGAGCGCTGC TCAGATAGCG ATGGTCTGGC CCCTCCTCAG CATCTTATCC GAGTGGAAGG 781 AAATTTGCGT GTGGAGTATT TGGATGACAG AAACACTTTT CGACATAGTG TGGTGGTGCC 841 CTATGAGCCG CCTGAGGTTG GCTCTGACTG TACCACCATC CACTACAACT ACATGTGTAA 901 CAGTTCCTGC ATGGGCGGCA TGAACCGGGA GGCCCATCCT CACCATCATC ACACTGGAAG 961 ACTCCAGTGG TAATCTACTG GGACGGAACA GCTTTGAGTG CGTGTTTGTG CCTTGTCCTG 1021 GAGAGACCGG GCGGCACAGA AGGAAGGAGA ATCTTCCGGC AAGAAAAGGG GAGCCTTCAC 1081 CACGGGAGCC TGCCTCCAAG GGAAGCACTT AAGACGGAGC CACTGCCCAC AACTCCAGCT 1141 TCCTCTCTCC CCAGCCAAGG AGGAAACACA CTTGGCATAT GAAGAAATAT AAT // |
Primer: BGH_rev Sequence file: RDB13744_A5Lob.seq ![]() |
>06754_13744_A5Lo_BGHrev_B03_06.ab1 1 GTCCTGCATT GGTGAACTAT AGAATAGGGC CCTCTAGATG CATGCTCGAG CGGCCTCAGT 61 CTGAGTCAGG CCCTTCTGTC TTGAACATGA GTTTTTTATG GCGGGAGGTA GACTGACCCT 121 TTTTGGACTT CAGGTGGCTG GAGTGAGCCC TGCTCCCCCC TGGCTCCTTC CCAGCCTGGG 181 CATCCTTGAG TTCCAAGGCC TCATTCAGCT CTCGGAACAT CTCGAAGCGC TCACGCCCAC 241 GGATCTGAAG GGTGAAATAT TCTCCATCCA GTGGTTTCTT CTTTGGCTGG GGAGAGGAGC 301 TGGTGTTGTT GGGCAGTGCT CGCTTAGTGC TCCCTGGGGG CAGCTCGTGG TGAGGCTCCC 361 CTTTCTTGCG GAGATTCTCT TCCTCTGTGC GCCGGTCTCT CCCAGGACAG GCACAAACAC 421 GCACCTCAAA GCTGTTCCGT CCCAGTAGAT TACCACTGGA GTCTTCCAGT GTGATGATGG 481 TGAGGATGGG CCTCCGGTTC ATGCCGCCCA TGCAGGAACT GTTACACATG TAGTTGTAGT 541 GGATGGTGGT ACAGTCAGAG CCAACCTCAG GCGGCTCATA GGGCACCACC ACACTATGTC 601 GAAAAGTGTT TCTGTCATCC AAATACTCCA CACGCAAATT TCCTTCCACT CGGATAAGAT 661 GCTGAGGAGG GGCCAGACCA TCGCTATCTG AGCAGCGCTC ATGGTGGGGG CAGCGCCTCA 721 CAACCTCCGT CATGTGCTGT GACTGCTTGT AGATGGCCAT GGCGCGGACG CGGGTGCCGG 781 GCGGGGGTGT GGAATCAACC CACAGCTGCA CAGGGCAGGT CTTGGCCAGT TGGCAAAACA 841 TCTTGTTGAG GGCAGGGGAG TACGTGCAAG TCACAGACTT GGCTGTCCCA GAATGCAAGA 901 AGCCCAGACG GAAACCGTAG CTGCCCTGGT AGGTTTTCTG GGAAAGGGAC AGAAGATGAC 961 AGGGGCCAGG AGGGGGCTGG GTGCAGGGCC CGCCGGGTGT AGAGCTGCTG GGTGCAGGGC 1021 CACGGGGGGG AGCAGCCTCT GGCATTCTGG GAGCTTCATC TGGGACCTGG GGTCTCAGTG 1081 ACCATGATCA ATATCGTCCG GGACGCATCC AATTCATTCA TGCTGGGACG GCAAGGGGGA 1141 ACAGAAACGG // |
Primer: SV40pro_F_V2 Sequence file: RDB13744_A5Loc.seq ![]() |
>06754_13744_A5Lo_SV40pro_F_V2_E12_15.ab1 1 GAACTTTTTT GGAGCTAGGC TTTTGCAAAA GCTCCCGGGA GCTTGGATAT CCATTTTCGG 61 ATCTGATCAA GAGACAGGAT GAGGATCGTT TCGCATGATT GAACAAGATG GATTGCACGC 121 AGGTTCTCCG GCCGCTTGGG TGGAGAGGCT ATTCGGCTAT GACTGGGCAC AACAGACAAT 181 CGGCTGCTCT GATGCCGCCG TGTTCCGGCT GTCAGCGCAG GGGCGCCCGG TTCTTTTTGT 241 CAAGACCGAC CTGTCCGGTG CCCTGAATGA ACTGCAGGAC GAGGCAGCGC GGCTATCGTG 301 GCTGGCCACG ACGGGCGTTC CTTGCGCAGC TGTGCTCGAC GTTGTCACTG AAGCGGGAAG 361 GGACTGGCTG CTATTGGGCG AAGTGCCGGG GCAGGATCTC CTGTCATCTC ACCTTGCTCC 421 TGCCGAGAAA GTATCCATCA TGGCTGATGC AATGCGGCGG CTGCATACGC TTGATCCGGC 481 TACCTGCCCA TTCGACCACC AAGCGAAACA TCGCATCGAG CGAGCACGTA CTCGGATGGA 541 AGCCGGTCTT GTCGATCAGG ATGATCTGGA CGAAGAGCAT CAGGGGCTCG CGCCAGCCGA 601 ACTGTTCGCC AGGCTCAAGG CGCGCATGCC CGACGGCGAG GATCTCGTCG TGACCCATGG 661 CGATGCCTGC TTGCCGAATA TCATGGTGGA AAATGGCCGC TTTTCTGGAT TCATCGACTG 721 TGGCCGGCTG GGTGTGGCGG ACCGCTATCA GGACATAGCG TTGGCTACCC GTGATATTGC 781 TGAAGAGCTT GGCGGCGAAT GGGCTGACCG CTTTCCTCGT GCTTTACGGT ATCGCCCGCT 841 CCCGATTCGC AGCGCATCGC CTTCTATCGC CCTTCTTGAC GAGTTCTTCT GAGCGGGACT 901 CTGGGGGTTC GAAATGACCG AACCAGCGAC GCCCAACCTG CATCACGAGA TTTCGATCAA 961 CGGCGCTTCC TATGAAAGGT GGCTCCGATC GTTTTCCGGA CGCGCTGATG ATCTCAGCGC 1021 GGCAATCTCA TGCTGAGAGG T // |
Please visit Sequencing and PCR primers for primer information.
Original, user report and related articles
user_report | Shimizu, H., NF-kappaB plays an important role in indoxyl sulfate-induced cellular senescence, fibrotic gene expression, and inhibition of proliferation in proximal tubular cells. Am. J. Physiol. Cell Physiol. 301 (5): C1201-12 (2011). PMID 21832251. [link to RRC of NBRP] |
---|
Featured content